脑血栓患者应用肠溶阿司匹林联合双嘧达莫治疗的临床疗效分析

发布时间：2018-04-16 07:29

本文选题：脑血栓 + 肠溶阿司匹林　；参考：《中国医药指南》2016年32期

【摘要】：目的分析脑血栓患者应用肠溶阿司匹林联合双嘧达莫治疗的临床疗效。方法选取2013年6月至2015年5月收治的108例脑血栓患者按随机数字表法分成观察组和对照组,每组各54例。对照组采用肠溶阿司匹林进行治疗,观察组采用肠溶阿司匹林联合双嘧达莫进行治疗。对比两组的治疗效果、不良反应及治疗前、后的神经功能缺损程度。结果观察组治疗的总有效率明显高于对照组(P0.05);两组不良反应发生率无明显差别(P0.05);两组治疗前神经功能缺损程度得分均无明显差别(P0.05);观察组治疗后神经缺损功能得分明显低于对照组(P0.05)。结论脑血栓患者采用肠溶阿司匹林联合双嘧达莫进行治疗能有效的提高治疗效果和促进患者神经功能的改善,且不良反应少。
[Abstract]:Objective to analyze the clinical effect of enteric aspirin combined with dipyridamole in patients with cerebral thrombosis.Methods 108 patients with cerebral thrombosis from June 2013 to May 2015 were randomly divided into observation group (n = 54) and control group (n = 54).The control group was treated with enteric aspirin and the observation group with enteric aspirin combined with dipyridamole.The therapeutic effect, adverse reaction and the degree of nerve function defect before and after treatment were compared between the two groups.Results the total effective rate of treatment in the observation group was significantly higher than that in the control group (P 0.05), there was no significant difference in the incidence of adverse reactions between the two groups (P 0.05), and there was no significant difference in the score of nerve function defect between the two groups before and after treatment (P 0.05).The score was significantly lower than that in the control group (P 0.05).Conclusion the combination of enteric aspirin and dipyridamole in patients with cerebral thrombosis can effectively improve the therapeutic effect and improve the neurological function of the patients, and the adverse reactions are few.
【作者单位】：湖南省怀化市第二人民医院神经内科;
【分类号】：R743.32

【相似文献】